Detalhe da pesquisa
1.
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.
Cell
; 184(13): 3486-3501.e21, 2021 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34077751
2.
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.
Cell
; 169(5): 891-904.e15, 2017 May 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28525756
3.
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
PLoS Pathog
; 20(4): e1012134, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38603762
4.
Protocadherin-1 is essential for cell entry by New World hantaviruses.
Nature
; 563(7732): 559-563, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30464266
5.
Long-term Sudan virus Ebola survivors maintain multiple antiviral defense mechanisms.
J Infect Dis
; 2023 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38066574
6.
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19.
Antimicrob Agents Chemother
; 67(1): e0135322, 2023 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36519929
7.
Development of an antibody cocktail for treatment of Sudan virus infection.
Proc Natl Acad Sci U S A
; 117(7): 3768-3778, 2020 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-32015126
8.
Monoclonal antibody therapy for Junin virus infection.
Proc Natl Acad Sci U S A
; 113(16): 4458-63, 2016 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27044104
9.
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
Nature
; 477(7364): 340-3, 2011 Aug 24.
Artigo
Inglês
| MEDLINE | ID: mdl-21866103
10.
Ebola virus entry requires the host-programmed recognition of an intracellular receptor.
EMBO J
; 31(8): 1947-60, 2012 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-22395071
11.
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.
Proc Natl Acad Sci U S A
; 109(13): 5034-9, 2012 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-22411795
12.
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.
J Virol
; 87(9): 4952-64, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23408633
13.
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).
J Infect Dis
; 208(2): 299-309, 2013 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23585686
14.
Engineering, structure, and immunogenicity of a Crimean-Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex.
bioRxiv
; 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38659837
15.
Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38.
bioRxiv
; 2024 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38496658
16.
Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus.
J Virol
; 86(5): 2809-16, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22171276
17.
Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection.
Nat Commun
; 14(1): 4454, 2023 07 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37488123
18.
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.
Sci Transl Med
; 14(635): eabl8124, 2022 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35076282
19.
Persistent immune responses after Ebola virus infection.
N Engl J Med
; 369(5): 492-3, 2013 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23902512
20.
Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
Front Immunol
; 12: 729851, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34721393